International Vaccine Institute

Analysis

International Vaccine Institute is a registered charity in United States, based in Republic of Korea. It received its IRS tax-exemption ruling in February 1999, 27 years ago. Its declared purposes cover international, foreign affairs and national security, which this site groups under overseas aid and international. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3).

In the financial year ending December 2023, International Vaccine Institute reported income of $96.6m and spending of $77.7m, spending 80% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $31.3m to $96.6m (+208%), an average of +32% a year. The sharpest change came in the year to December 2020, when income rose by 72%. Over the whole period it spent 81% of the income it received.

Among 10,317 United States charities whose main cause is overseas aid and international and that reported income, International Vaccine Institute sits at the 99th percentile: it is one of the largest 1% in its cause. Against every charity in United States with reported income it ranks in the 99th percentile. Charities of a similar size with the same main cause include Adventist Development and Relief Agency International ($96.4m), Cambridge in America ($97.1m) and Operation Smile Inc ($95.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 91% of the total. Compensation of current officers, directors and key employees was $2.8m (3.6% of expenses). Other salaries and wages came to $15.3m. At year end it held assets of $104.8m against liabilities of $5.2m, net assets of $99.6m. It reported 247 employees.